Abstract. Novel drug excipients are required to achieve stable formulations of protein drug candidates. Synthetic glycopolymers have been shown in some cases to improve protein formulation stability, although their structure-function relationship remains unknown. Here we report the synthesis of linear or 4-arm star glycopolymers with different molecular topology and chemical composition, with mannose, galactose, arabinose, N-acetyl glucosamine, lactose and trehalose pendant units -and investigate their modulation of conformational stability and aggregation propensity of a model monoclonal antibody (mAb1). Mono-and di-saccharides with free reducing ends are not frequently utilised as protein stabilisers, due to potential reactivity with a protein's amine groups. In this study this was circumvented through the use of a stable acetal linker connecting the polymer backbone to the sugar pendant residues, which made the latter virtually non-reactive with amines. The general destabilisation the antibody was determined as anunfolding transition temperature (Tm) of CH2 and Fab structural domains, and aggregation temperature (Tagg). The most prominent effect of the glycopolymers on a temperature induced stress in a low concentration solutions was a decrease in Tm and Tagg, regardless of sugar composition or glycopolymer topologyin contrast to the stabilising effect of the corresponding mono-and di-saccharide constituents. The exceptions of linear-lactose and star-trehalose glycopolymers, which increased Tm of the mAb Fab region and Tagg, however, highlights a more complex structure-function relationship. Accelerated stability studies of the high concentrated mAb solutions (50 mg mL-1) revealed that the increased glycopolymer concentrations generally decreased the mAb stability, as judged by the amount of mAb1 'monomer' molecules in solution, with star-and linear-trehalose glycopolymers further generating visible aggregates. Interestingly the latter effect could not have been predicted from the Tm or Tagg experiments conducted at a low concentration regime. Taken together, the data demonstrate a complex interplay of sugar chemistry and molecular topology of the synthetic glycopolymers on their modulation of protein conformational stability and aggregation propensity. Solution concentration was also an important parameter contributing to the stability modulation, and suggests that the stabilising properties of a sugar as the mono-or di-saccharide cannot be extrapolated to the corresponding glycopolymers.
Introduction
Biopharmaceuticals are a large segment of the pharmaceutical industry, representing over 40% of the products currently in the industrial R&D pipeline, with an estimated annual revenue of about $75 billion worldwide.
1 Development of protein pharmaceuticals is challenging, with a number of hurdles that need to be overcome. 2, 3 Most biotherapeutics can degrade at various stages of their preparation/utilisation -e.g. bioprocessing, storage and transport -hence requiring special precautions, such as controlled temperature and pH, and the addition of stabilising excipients. [4] [5] [6] [7] Amongst the physical instability pathways, protein aggregation is arguably the most common and often problematic, and can result from physical and/or chemical insults at all phases of the development process. 2 The underlying challenge in protein formulation is to retain the native conformation of the biotherapeutic, which relies on a complex and often fragile network of intramolecular non-covalent interactions. These include ion pairing, H-bonding and other dipolar forces, π-effects, and van der Waals interactions, all of which can be affected by the physico-chemical conditions of the surrounding medium. Upon unfolding and subsequent irreversible aggregation, protein therapeutics may present reduced or even suppressed activity, decreased solubility, and altered immunogenicity. 8 A number of strategies have been developed to address this issue, with variable success. 9 An important approach for stabilising protein formulations involves the use of excipients.
These can be diverse in chemistry and function, and include salts, carbohydrates, proteins and polymers. [10] [11] [12] [13] Low molecular weight sugars -e.g. mono-or disaccharides -and polyols are important classes of protein stabilisers which can minimize both physical and chemical degradations pathways. 14, 15 Although their mechanisms of stabilisation are not fully understood, the preferential exclusion/hydration hypothesis describes the exclusion of a sugar is excluded from the protein surface. In turn, this can thermodynamically favour the protein conformation with the smallest surface area (generally corresponding to its native state). 16, 17, 18 A recent study by Maynard and co-workers has shown that appropriately designed trehalose glycopolymers are superior to their isolated low molecular weight trehalose disaccharide components in their ability to help a model protein, lysozyme, to retain its enzymatic activity after stress stimuli, when. 19 This pioneering work suggested that both the 'local' concentration and spatial arrangement of sugar within glycopolymers played a role in preventing protein aggregation and retaining enzymatic activity. Similar to low molecular weight sugars, the mechanisms by which glycopolymers influence protein structural stability and aggregation are still largely unknown, especially in regards to the role of macromolecular features -size, macromolecular architecture and dispersity -and the chemical nature of the carbohydrate repeating units.
The present study addresses this important point, with a specific focus on how synthetic glycopolymers can affect the conformational and colloidal stability of formulations of monoclonal antibodies (mAbs). Here, two different homopolymer libraries were synthesised:
linear glycopolymers containing a range of carbohydrates -mannose, galactose, arabinose, Nacetyl glucosamine, lactose or trehalose-in their repeating units, and their corresponding 4-arm star shaped glycopolymer analogues. More specifically, this work was aimed at investigating structure/function relationships for this class of synthetic macromolecules by systematically varying polymer structural parameters. The nature of the sugar repeating units and the macromolecular architecture were assessed for their influence on protein structural stability and aggregation behaviour.
Experimental MATERIALS AND METHODS
Monoclonal antibody. The monoclonal antibody (mAb1) used in this study is a bi-specific antibody (IgG1), with a molecular weight of 204 kDa and was provided by MedImmune (Cambridge, UK). The mAb has three distinct unfolding transition temperatures (Tm,CH2, Tm,Fab, Tm,CH3), with an experimentally determined isoelectric point (pI) of 9.
Equipment. All polymerisation reactions were carried out using standard Schlenk techniques under an inert atmosphere of oxygen-free nitrogen, unless otherwise stated. TLC was performed using pre-coated silica gel 60 F254 and developed in the solvent systems indicated.
Compounds were visualized by KMnO4 staining. Merck 60 (230-400 mesh) silica gel was used for column chromatography. Molar mass distributions were measured using size exclusion chromatography (SEC).
Size exclusion chromatography -Multi-angle static light scattering (SEC-MALS Chromatography (SE-HPLC). At time zero samples were run and the area under the curve (AUC) of the peak for native mAb1 (here referred to as monomer as a reference to oligomeric or aggregated and/or degradation products) was calculated. The degradation of mAb1 was assessed via integration of the AUC of the monomer peak in comparison to the integration of the AUC of all the peaks appearing in subsequent weeks, as described by Kheddo, et al. 22 The samples were tested weekly by SE-HPLC, using a Shimadzu HPLC system (LC-20 AP pump), equipped with a SPD-M20A UV detector and SIL-20A autosampler. A Tosoh TSKgel column was used, with 5 L samples being injected each time, with DPBS as the mobile phase, with UV detection at λ = 280 nm.
Statistics. Statistical analyses were carried out using GraphPad Prism v6. The statistical significance of differences between groups was determined using one-way ANOVA, comparing the values of the mAb alone with mAb runs in the presence of excipients. Comparisons were considered non-significant, * p < 0.05, or ** p < 0.01.
Results and discussion
Synthesis of glycopolymers. In this work, sugar-based polymers were synthesised by postpolymerisation modification of functional polymers with a range of complementarily reactive carbohydrates, as described by Ladmiral et al, 23 For mannose, galactose and arabinose, the monosaccharide starting materials were suspended in an excess of 2-bromoethanol and heated at 90 °C in the presence of Amberlite 120H acid catalyst. 24 The resulting 2'-bromoethyl glycoside intermediates were then treated with NaN3 in DMF to give the sugar azides required for polymer conjugation. A similar protocol was utilised for the synthesis of 2'-azidoethyl N-acetyl glucosamine, with the difference that
HBr generated in situ with acetyl bromide was utilised as the catalyst to generate the required 2'-bromoethyl glycoside intermediate (8d). This procedure -direct conversion of sugars into their corresponding alkyl bromide glycosides followed by treatment with NaN3 -was found to be particularly suited for the functionalization of monosaccharides, which was achieved in only two steps from commercially available carbohydrates, and did not require protection/deprotection of the sugar hydroxyl groups. (Table 1) . Design of stability studies of mAb1. Amongst sugars investigated in this study, trehalose is a commonly used formulation excipient, due to its demonstrated ability to stabilise conformational and solution colloidal properties of antibodies. 32, 33, 34 In contrast, monosaccharides mannose, galactose, arabinose and N-acetyl glucosamine, or di-saccharide lactose, are not frequently utilised. 35 at least in part due to the hemiacetal ends of these sugars being reactive towards protein amino groups, through a series of side-processes that include formation of imines and Maillard reactions. 36, 37, 38, 39 In the present study, this issue was undergoes a bathochromic shift, typically from ~335 to 355 nm, which occurs when, upon heatinduced denaturation, Trp residues buried within hydrophobic protein domains become exposed to a more polar aqueous environment,. 20, 43, 44 It should be noted that the intrinsic fluorescence measurements reported in Figure 1 (values for mAb1 alone) are in agreement with DSC data for the mAb1 unfolding transitions ( Figure S46 and Table S1 ). Tm indicates the mid-point temperature of the transition from native to a fully unfolded conformation for mAb1 in solution, and an increase in Tm in the presence of an excipient is considered to be indicative of enhanced conformational stability. 20, 40, 41 Changes in mAb1 unfolding transition temperatures in the presence of low molecular weight sugars and glycopolymers ranged from 0.1 °C to 3.22 °C (Figure 1) . In previous studies differences of ± 0.2 °C have been reported, and utilised to discriminate between different formulations. 45 Amongst low molecular weight mono-and di-saccharide excipients, trehalose produced an overall stabilising effect on mAb unfolding, as judged from an increase of Tm for all three mAb domains ( Figure 1) ; which is in agreement with previous studies. 33, 34, 46, 47 Similarly, the stabilising profile of lactose was in agreement with reports for other disaccharides, such as sucrose 41, 48 . For other tested sugars, increases in Tm,CH2 and Tm,Fab were observed; the latter being particularly prominent for galactose and arabinose. The effect on Tm of CH3 domain was found to be more dependent on the nature of the sugar utilised, with, in general, d estabilising effects of monosaccharides, particularly galactose, and stabilisingstabilisation provided by disaccharides, particularly trehalose. Since reducing monosaccharides are not commonly used to stabilise protein formulations, comparative data are not easily available.
For the linear and star glycopolymers (13a-f) and (16a-f), respectively, and at low mAb1 concentration (1.0 mg mL Published work on structural stability of IgGs in the presence of different excipients suggests that the CH2 domain, the most unstable in response to thermal and chemical insults, may determine the overall physical stability of mAbs. 41, 49 Applied to the present study, the overall decrease of the Tm,CH2 induced by all the tested glycopolymers regardless of composition or molecular architecture might therefore suggest that under the exerimental conditions investigated, these glycopolymers mostly exert an overall destabilising effect on the mAb.
The effect of sugars and glycopolymers on mAb1 thermally induced aggregation. SLS analysis
provided an insight into the colloidal stability of mAb1 samples towards aggregation ( Figure   2 ). It has been proposed that, upon unfolding, non-native protein conformations expose hydrophobic 'patches' which can initiate self-association through non-reversible and nonspecific assembly pathways, leading to the formation of soluble and insoluble aggregates. expected to overlap, as they are related to distinct structural and kinetic phenomena. 51 Aggregation temperatures (Tagg) lower than Tm have been described for a number of proteins, 52 and could be attributed to thermally induced self-association prior to denaturation, which in turn may lead to subsequent denaturation. In addition, Tm is defined as the mid-point of unfolding transition, thus it does not accurately define the onset of the process. In systems where a relatively low proportion of unfolded proteins can initiate the formation of aggregates, Tagg < Tm may be observed.
Under the stress conditions employed in this work, Tagg of mAb1 alone (60.6 °C) was found to be lower than Tm values of CH2, Fab and CH3 domains (Figure 1 ), indicating the antibody propensity to initiate aggregation at low levels of molecular unfolding. Statistical significance, ** = p < 0.01.
A more detailed inspection of SLS profiles for the mAb1 alone, and its sugar and glycopolymer formulations (representative examples shown in Figure S47 ) revealed a two-step aggregation process with a small increase just above 60 °C and an incremental, larger increase at temperatures above ~ 70 °C. It should be noted that trehalose glycopolymers showed a less pronounced initial step compared to the other glycopolymers( Figure S47 ), resulting in higher estimated Tagg values. In general, the addition of mono-or di-saccharides to mAb1 solutions over all concentrations ratios tested did not result in a significant modulation of the antibody's Tagg over all concentrations tested (Figure 2 ). In contrast, the linear-and star-glycopolymers based on monosaccharides mannose and galactose appeared to promote thermally induced mAb1 aggregation, resulting in a decrease in Tagg of up to 3 °C. The opposite was observed for di-saccharide-based glycopolymers, where 4-arm lactose and trehalose glycopolymers, as well as the linear trehalose glycopolymer at specific concentrations, generally raised the Tagg of mAb1 (although the Tagg values estimated for trehalose polymers need to be viewed with some caution, as discussed above).
In terms of sugar:mAb ratios, the linear glycopolymers , induced a more pronounced decrease in the Tagg at the higher ratios with the exception of the N-acetyl glucosamine (13d) polymer at the highest ratio. In formulations containing trehalose linear glycopolymer (13f), a stabilising effect was observed at lower concentrations (1:1 and 100:1 molar ratios) and an increasing destabilising effect at higher concentrations (200:1 and 300:1), similar to the other linear polymer excipients.. Such concentration-dependent effect was found to be less pronounced for the 4-arms star library, with exception of the galactose polymer (16b). consistently decreased Tm,CH2 and Tagg (Figures 1 and 2 ).
Both lactose-and trehalose-based disaccharide-glycopolymers were investigated due to their rather different behaviour in previous conformational and colloidal stability experiments (Figures 1 and 2 ).
Trehalose as low molecular weight disaccharide displayed a clear positive effect on mAb1 conformational stability (increasing Tm values), which was lost as trehalose linear or star glycopolymers. In addition, colloidal stability SLS profiles for trehalose based were somewhat altered, compared to other glycopolymers( Figure S47 ). Lactose glycopolymers were selected as they induced less well-defined trends in the protein conformation and colloidal stability studies. In these experiments, the decrease in concentration of mAb native protein in solutionreferred to as mAb1 monomer to differentiate it from its oligomeric aggregation products formed over time -was monitored over seven weeks. mAb1 solution at 50 mg mL -1 was used in all formulations tested in this part of the study to mimic the high concentrations of antibody solutions often required for pharmaceutical products. Additionally, the use of a high concentration solution of mAb1 also allowed for better assessment of the loss of mAb1 monomer. 54 As in the previous experiments, the glycopolymers were added in four different sugar:mAb1 molar ratios.
The resulting stability profiles indicate that, in general, increasing sugar:protein molar ratio resulted in a decrease in native mAb1 (monomer) content over time, for all formulations tested, at both 25 and 40 °C (Figure 3) . Interestingly, mannose glycopolymers (13a) and (16a), which showed clear destabilising effect in protein conformation and stability tests, appeared to produce relatively modest destabilising effect on long term stability of the mAb1 solutions, even at 300:1 sugar:mAb1 ratios, i.e. concentrated glycopolymer solutions. This is in contrast to mAb1 solutions containing trehalose glycopolymers (13a) and (16a). Stabilization of antibody unfolding, i.e increased Tm and Tagg was seen at lower sugar:mAb1 ratio (100:1), whilst at the higher mAb1 concentration utilised in these accelerated stability studies (50 mg mL It is commonly accepted that hydrophilic polymers can increase the conformational stability of mAbs by the excluded volume effect and/or preferential exclusion mechanisms. 41 The glycopolymers should, therefore, exclude themselves from the protein surface, forcing the protein to stay in a preferential hydrated state, adopting more compact conformations, which often correspond (or are closely related) to the protein native conformation. 24, 55 However, such an exclusion of excipients from the vicinity of protein macromolecules can sometimes result in microenvironments with higher protein local concentration, which favours proteinprotein interactions, and may eventually lead to protein aggregation. This effect is often more pronounced at high protein concentrations, 56,57 such as 50 mg mL -1 utilised for this study.
Accordingly, particular glycopolymer compositions or molecule architectures lead to different macromolecular crowding effects, hence resulting in mAb1 aggregation to a different extents.
Interestingly, SEC analysis of trehalose glycopolymers (13f) and (16f) in aqueous conditions showed that, whilst possessing a narrow dispersity Ð (1.18 for linear (13f) and 1.17 for star (16f) which are slightly narrower than that of the other glycopolymers), these polymers had hydrodynamic volumes higher than expected when compared to poly(ethylene glycol) narrow standards used as SEC calibrants, a phenomenon that is in line with a previous report by Maynard and co-workers for styrene-based trehalose polymers. 19 In our study we found that trehalose glycopolymers (13f) and (16f) had a molecular weight slightly higher than that of disaccharide lactose (13e) and (16e) (37.6 vs. 25.5 kDa for linear, 55.9 vs. 42.6 kDa for star glycopolymers, for trehalose and lactose, respectively; Table 1 ). Although studies on the detailed mechanism of these protein aggregation phenomena are currently on-going, the higher hydrodynamic volume of trehalose glycopolymers might explain the distinctive behaviour of solutions containing these glycopolymers in the accelerated stability studies.
These results are in agreement with previous work by Miura and co-workers, who showed that the fibrillation of Aβ(1-40) was favoured for polyacrylamide-based linear glycopolymers with trehalose moieties present at each polymer repeating unit -thus structurally analogous to (13f).. 58 Interestingly, these authors also found that when their trehalose monomer was copolymerised with an excess of acrylamide, a significantly smaller, hydrophilic monomer, the resulting materials could reduce fibrillation of Aβ(1-40). This trend could be ascribed, at least in part, to the different macromolecular crowding provided by trehalose homo-and copolymers investigated in their work.
Simultaneous study of the conformational and colloidal stability of protein formulations are of great importance to understand the phenomena underpinning the lack of long-term stability of a number of potential mAb biotherapeutics. The stability of the CH2 domain appeared to be governing the overall behaviour of mAb1; the glycopolymers solutions that decreased Tm,CH2 resulted in decreased mAb1 monomer content, i.e. presence of antibody aggregation in the accelerated stability studies. For the latter, trehalose polymers overall produced the most marked effect on the colloidal stability of mAb1, with visible precipitation observed from as early as week two. Although the distinctiveness of the colloidal stability profile of the trehalose polymers (Tagg, Figure S47 ) was noticed during initial characterisation stage, it was only during the accelerated stability studies that the extent of mAb1 aggregation was appreciated, due to the visible precipitates.
Overall, the trend of decreased conformational and colloidal stability of mAb1, assessed from intrinsic fluorescence and static light scattering measurements (Tm,CH2 and Tagg) of thermally stressed formulations, appears to be generally in line the trends from accelerated stability studies, despite high antibody concentrations in the latter, therefore suggesting that screening of Tm and Tagg could be employed to predict the stability of selected mAbs. Moreover, the polymers often destabilised the protein in solution to a greater extent at higher concentrations. Interestingly, this induction of mAb1 aggregation was particularly pronounced for trehalose-based glycopolymers, especially at their higher concentrations, and was only appreciated in long term stability studies. It is notable that effects of low molecular weight sugar excipients cannot be extrapolated to effects of corresponding glycopolymers and that often at higher concentrations of glycopolymers in solution induction of antibody unfolding and/or aggregation, rather than stabilisation to aggregation, prevails. More studies of the mechanisms involved are still required to understand this phenomenon and are currently being undertaken. This study also suggests that the use of glycopolymers as excipients of protein liquid formulations is very much dependent on the physico-chemical characteristics of these macromolecular materials (and possibly on the nature of the protein therapeutic of choice), hence their suitability as stabilisers for protein liquid formulations needs to be evaluated on a case by case basis.
Conclusions

